Cross-talk of expression quantitative trait loci within 2 interacting blood pressure quantitative trait loci

Hypertension

Volumn 50, Issue 6, 2007, Pages 1126-1133

  Lee, Norman H ^a,b,d   Haas, Brian J ^b   Letwin, Noah E ^a   Frank, Bryan C ^a   Luu, Truong V ^a   Sun, Qiang ^b   House, Carrie D ^a   Yerga Woolwine, Shane ^c   Farms, Phyllis ^c   Manickavasagam, Ezhilarasi ^c   Joe, Bina ^c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b J CRAIG VENTER INSTITUTE   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Congenic; Dahl salt sensitive rat; Gene; Hypertension; Inbred

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONGENIC STRAIN; GENE EXPRESSION; GENE INTERACTION; GENETIC TRANSCRIPTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT;

ALKANE 1-MONOOXYGENASE; ANIMALS; BLOOD PRESSURE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HYPERTENSION; KIDNEY; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); QUANTITATIVE TRAIT LOCI; RATS; TRANSCRIPTION FACTORS;

EID: 36448950487     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.093138     Document Type: Article

References (59)

1. Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet. 2006;7:829-840.
2. Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiol Rev. 2000;80:135-172.
3. Joe B, Garrett MR. Substitution mapping: using congenic strains to detect genes controlling blood pressure. In: Raizada MK, Payton JFR, Kasparov S, Katovich MJ, ed. Cardiovascular Genomics. Humana Press Inc; 2005:41-58.
4. Joe B, Garrett MR. Genetic analysis of inherited hypertension in the rat. In: Dominiczak A, Connell J, eds. Genetics of Hypertension. Amerstam, The Netherlands: Elsevier Science; 2006;24:177-200.
5. Pravenec M, Kurtz TW. Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies. Hypertension. 2007;49:941-952.
6. Deng AY. Positional cloning of quantitative trait loci for blood pressure: how close are we?: a critical perspective. Hypertension. 2007;49:740-747.
7. Jacob HJ, Kwitek AE. Rat genetics: attaching physiology and pharmacology to the genome. Nat Rev Genet. 2002;3:33-42.
8. McBride MW, Carr FJ, Graham D, Anderson NH, Clark JS, Lee WK, Charchar FJ, Brosnan MJ, Dominiczak AF. Microarray analysis of rat chromosome 2 congenic strains. Hypertension. 2003;41:847-853.
9. McBride MW, Brosnan MJ, Mathers J, McLellan LI, Miller WH, Graham D, Hanlon N, Hamilton CA, Polke JM, Lee WK, Dominiczak AF. Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension. 2005;45:786-792.
10. Saad Y, Garrett MR, Manickavasagam E, Yerga-Woolwine S, Farms P, Radecki T, Joe B. Fine-mapping and comprehensive transcript analysis reveals nonsynonymous variants within a novel 1.17 Mb blood pressure QTL region on rat chromosome 10. Genomics. 2007;89:343-353.
11. Garrett MR, Meng H, Rapp JP, Joe B. Locating a blood pressure quantitative trait locus within 117 kb on the rat genome: substitution mapping and renal expression analysis. Hypertension. 2005;45:451-459.
12. Garrett MR, Rapp JP. Defining the blood pressure QTL on chromosome 7 in Dahl rats by a 177kb congenic segment containing Cyp11b1. Mamm Genome. 2003;14:268-273.
13. Joe B, Garrett MR, Dene H, Rapp JP. Substitution mapping of a blood pressure quantitative trait locus to a 2.73 Mb region on rat chromosome 1. J Hypertens. 2003;21:2077-2084.
14. Saad Y, Yerga-Woolwine S, Saikumar J, Farms P, Manickavasagam E, Toland EJ, Joe B. Congenic interval mapping of RNO10 reveals a complex cluster of closely-linked genetic determinants of blood pressure. Hypertension. In press.
15. Garrett MR, Rapp JP. Two closely linked interactive blood pressure QTL on rat chromosome 5 defined using congenic Dahl rats. Physiol Genomics. 2002;8:81-86.
16. Malek RL, Wang HY, Kwitek AE, Greene AS, Bhagabati N, Borchardt G, Cahill L, Currier T, Frank B, Fu X, Hasinoff M, Howe E, Letwin N, Luu TV, Saeed A, Sajadi H, Salzberg SL, Sultana R, Thiagarajan M, Tsai J, Veratti K, White J, Quackenbush J, Jacob HJ, Lee NH. Physiogenomic resources for rat models of heart, lung and blood disorders. Nat Genet. 2006;38:234-239.
17. Petretto E, Mangion J, Dickens NJ, Cook SA, Kumaran MK, Lu H, Fischer J, Maatz H, Kren V, Pravenec M, Hubner N, Aitman TJ. Heritability and tissue specificity of expression quantitative trait loci. PLoS Genet. 2006;2:e172.
18. Petretto E, Mangion J, Pravanec M, Hubner N, Aitman TJ. Integrated gene expression profiling and linkage analysis in the rat. Mamm Genome. 2006;17:480-489.
19. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet. 1999;21:76-83.
20. Pravenec M, Wallace C, Aitman TJ, Kurtz TW. Gene expression profiling in hypertension research: a critical perspective. Hypertension. 2003;41:3-8.
21. Liang M, Yuan B, Rute E, Greene AS, Zou AP, Soares P, McQuestion GDK, Slocum GR, Jacob HJ, Cowley AW Jr. Renal medullary genes in salt-sensitive hypertension: a chromosomal substitution and cDNA microarray study. Physiol Genomics. 2002;8:139-149.
22. Liang M, Yuan B, Rute E, Greene AS, Olivier M, Cowley AW Jr. Insights into Dahl salt-sensitive hypertension revealed by temporal patterns of renal medullary gene expression. Physiol Genomics. 2002;12:229-237.
23. Liang M, Cowley AW Jr, Greene AS. High throughput gene expression profiling: A molecular approach to integrative physiology. J Physiol. 2003;554.1:22-30.
24. Lee SJ, Liu J, Qi N, Guarnera RA, Lee SY, Cicila GT. Use of a panel of congenic strains to evaluate differentially expressed genes as candidate genes for blood pressure quantitative trait loci. Hypertens Res. 2003;26:75-87.
25. Joe B, Letwin NE, Garrett MR, Dhindaw S, Frank B, Sultana R, Verratti K, Rapp JP, Lee NH. Transcriptional profiling with a blood pressure QTL interval-specific oligonucleotide array. Physiol Genomics. 2005;23:318-326.
26. Lee NH. Physiogenomic strategies and resources to associate genes with rat models of heart, lung and blood disorders. Exp Physiol. 2007;1-11.
27. Malek RL, Irby RB, Guo QM, Lee K, Wong S, Ruffy M, Tsai J, Kwong KY, Frank B, Liu ET, Quackenbush J, Jove R, Yeatman T, Lee NH. Identification of Src transformation fingerprint in human colon cancer. Oncogene. 2002;21:7256-7265.
28. Wang HY, Malek RL, Luu TV, Behbahani B, Frank B, Quackenbush J, Lee NH. Assessing unmodified 70-mer oligonucleotide probe performance against traditional PCR amplicons on glass slide microarrays. Genome Biol. 2003;4:R5.
29. Lee NH. Genomic approaches for reconstructing gene networks. Pharmacogenomics. 2005;6:245-258.
30. Irby RB, Malek RL, Bloom G, Tsai J, Letwin N, Frank BC, Verratti K, Yeatman TJ, Lee NH. Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype. Cancer Res. 2005;65:1814-1821.
31. Rapp JP, Dene H. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension. 1985;7:340-349.
32. Zicha J, Kunes J. Ontogenetic aspects of hypertension development: analysis in the rat. Physiol Rev. 1999;79:1227-1282.
33. Cowley AW Jr, Roman RJ. The role of the kidney in hypertension. JAMA. 1996;275:1581-1589.
34. Dahl LK, Knudsen KD, Iwai J. Genetic influence of the kidney in hypertension-prone rats. Circ Res. 1970;27(suppl 2):277+.
35. Hubner N, Wallace CA, Zimdahl H, Petretto E, Schulz H, Maciver F, Mueller M, Hummel O, Monti J, Zidek V, Musilova A, Kren V, Causton H, Game L, Born G, Schmidt S, Muller A, Cook SA, Kurtz TW, Whittaker J, Pravenec M, Aitman TJ. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet. 2005;37:243-253.
36. Arthur JW, Sanchez-Perez A, Cook DI. Scoring of predicted GRK2 phosphorylation sites in Nedd4-2. Bioinformatics. 2006;22:2192-2195.
37. Semela D, Langer DA, Shah V. GRK2 makes trouble: a no-NO in portal hypertension. Gastroenterology. 2006;130:1001-1003.
38. Liu S, Premont RT, Kontos CD, Zhu S, Rockey DC. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med. 2005;11:952-958.
39. Gros R, Chorazyczewski J, Meek MD, Benovic JL, Ferguson SS, Feldman RD. G-protein-coupled receptor kinase activity in hypertension: increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension. 2000;35:38-42.
40. Barbato A, Russo P, Venezia A, Strazzullo V, Siani A, Cappuccio FP. Analysis of Gly40Ser polymorphism of the glucagon receptor (GCGR) gene in different ethnic groups. J Hum Hypertens. 2003;17:577-579.
41. Strazzullo P, Iacone R, Siani A, Barba G, Russo O, Russo P, Barbato A, D'Elia L, Farinaro E, Cappuccio FP. Altered renal sodium handling and hypertension in men carrying the glucagon receptor gene (Gly40Ser) variant. J Mol Med. 2001;79:574-580.
42. Rutherford S, Boatwright SD, Samwell GA, Morris BJ, Griffiths LR. A linkage and cross-sectional study of hypertension and obesity using a poly (A) Alu-repeat polymorphism at the glucagon receptor gene locus (17q25). Clin Exp Pharmacol Physiol. 1998;25:627-629.
43. Behrends S, Vehse K, Scholz H, Bullerdiek J, Kazmierczak B. Assignment of GUCY1A3, a candidate gene for hypertension, to human chromosome bands 4q31.1->q31.2 by in situ hybridization. Cytogenet Cell Genet. 2000;88:204-205.
44. Hammer F, Stewart PM. Cortisol metabolism in hypertension. Best Pract Res Clin Endocrinol Metab. 2006;20:337-353.
45. Mariniello B, Ronconi V, Sardu C, Pagliericcio A, Galletti F, Strazzullo P, Palermo M, Boscaro M, Stewart PM, Mantero F, Giacchetti G. Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension. Am J Hypertens. 2005;18:1091-1098.
46. Morineau G, Sulmont V, Salomon R, Fiquet-Kempf B, Jeunemaitre X, Nicod J, Ferrari P. Apparent mineralocorticoid excess: report of six new cases and extensive personal experience. J Am Soc Nephrol. 2006;17:3176-3184.
47. Watson B Jr. Genetics of the kidney and hypertension. Curr Hypertens Rep. 2003;5:273-276.
48. Williams TA, Mulatero P, Filigheddu F, Troffa C, Milan A, Argiolas G, Parpaglia PP, Veglio F, Glorioso N. Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides. Kidney Int. 2005;67:631-637.
49. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol. 2004;37:449-471.
50. Olivier M, Hsiung CA, Chuang LM, Ho LT, Ting CT, Bustos VI, Lee TM, De Witte A, Chen YD, Olshen R, Rodriguez B, Wen CC, Cox DR. Single nucleotide polymorphisms in protein tyrosine phosphatase 1beta (PTPN1) are associated with essential hypertension and obesity. Hum Mol Genet. 2004;13:1885-1892.
51. Chan SH, Tai MH, Li CY, Chan JY. Reduction in molecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. Free Radic Biol Med. 2006;40:2028-2039.
52. Rodriguez-Iturbe B, Sepassi L, Quiroz Y, Ni Z, Wallace DC, Vaziri ND. Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence. J Appl Physiol. 2007;102:255-260.
53. Dunn SA, Mohteshamzadeh M, Daly AK, Thomas TH. Altered tropomyosin expression in essential hypertension. Hypertension. 2003;41:347-354.
54. Kuschnir E. The left ventricle and hemodynamic patterns in essential hypertension. Regul Pept. 2005;128:221-225.
55. Rizzoni D, Paiardi S, Rodella L, Porteri E, De Ciuceis C, Rezzani R, Boari GE, Zani F, Miclini M, Tiberio GA, Giulini SM, Rosei CA, Bianchi R, Rosei EA. Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism. J Clin Endocrinol Metab. 2006;91:2638-2642.
56. Szmigielski C, Raczkowska M, Styczynski G, Pruszczyk P, Gaciong Z. Metabolism of collagen is altered in hypertensives with increased intima media thickness. Blood Press. 2006;15:157-163.
57. Matsubara M. Renal sodium handling for body fluid maintenance and blood pressure regulation. Yakugaku Zasshi. 2004;124:301-309.
58. Roman RJ, Hoagland KM, Lopez B, Kwitek AE, Garrett MR, Rapp JP, Lazar J, Jacob HJ, Sarkis A. Characterization of blood pressure and renal function in chromosome 5 congenic strains of Dahl S rats. Am J Physiol Renal Physiol. 2006;290:F1463-F1471.
59. Stec DE, Roman RJ, Flasch A, Rieder MJ. Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics. 2007;30:74-81.